Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Net Sales
742.90
1,043.60
1,049.30
1,117.50
1,773.60
1,555.40
1,106.00
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
742.90
1,043.60
1,049.30
1,117.50
1,773.60
1,555.40
1,106.00
Raw Material Cost
392.30
738.40
756.80
750.40
803.70
552.10
467.40
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
59.30
71.00
96.80
37.20
28.70
27.40
39.00
Selling and Distribution Expenses
186.60
298.70
356.70
337.70
348.70
303.30
273.50
Other Expenses
-0.55
-0.61
1.10
15.11
20.65
17.81
18.72
Total Expenditure (Excl Depreciation)
632.70
1,102.00
1,221.30
1,276.40
1,387.60
1,060.90
967.10
Operating Profit (PBDIT) excl Other Income
110.19999999999999
-58.4
-172
-158.9
386
494.5
138.9
Other Income
54.20
36.80
92.00
-11.80
-9.50
4.70
1.70
Operating Profit (PBDIT)
262.70
90.40
49.10
-21.80
502.80
613.60
251.50
Interest
59.30
71.00
96.80
37.20
28.70
27.40
39.00
Exceptional Items
-22.30
-50.30
-554.40
-11.10
-44.60
-64.60
-24.20
Gross Profit (PBDT)
350.60
305.20
292.50
367.10
969.90
1,003.30
638.60
Depreciation
98.30
112.00
129.10
148.90
126.30
114.40
110.90
Profit Before Tax
82.80
-142.90
-731.20
-219.00
303.20
407.20
77.40
Tax
30.20
47.70
29.30
-7.40
83.70
102.10
22.90
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
52.60
-190.60
-760.50
-211.60
219.50
305.10
54.50
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
52.60
-190.60
-760.50
-211.60
219.50
305.10
54.50
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
52.60
-190.60
-760.50
-211.60
219.50
305.10
54.50
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
522.60
482.80
649.30
1,387.70
1,611.50
1,447.00
1,088.50
Earnings per share (EPS)
0.93
-3.6
-14.85
-4.22
4.06
5.67
1.04
Diluted Earnings per share
0.93
-3.6
-14.85
-4.22
4.06
5.67
1.04
Operating Profit Margin (Excl OI)
14.83%
-5.6%
-16.39%
-14.22%
21.76%
31.79%
12.56%
Gross Profit Margin
24.38%
-2.96%
-57.38%
-6.27%
24.22%
33.53%
17.03%
PAT Margin
7.08%
-18.26%
-72.48%
-18.94%
12.38%
19.62%
4.93%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Dec 2025 is -28.81% vs -0.54% in Dec 2024
Consolidate Net Profit
YoY Growth in year ended Dec 2025 is 127.60% vs 74.94% in Dec 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Dec 2025 is 288.99% vs 224.94% in Dec 2024
Interest
YoY Growth in year ended Dec 2025 is -16.48% vs -26.65% in Dec 2024
Operating Profit Margin (Excl OI)
YoY Growth in year ended Dec 2025 has improved from Dec 2024
Compare Annual Results Of Emergent BioSolutions, Inc. With
Figures in Million
Consolidate Annual Results
Change(USD)
Change(%)
Net Sales
742.90
2.07
740.83
35,788.89%
Other Operating Income
0.00
0.00
0.00
Total Operating income
742.90
2.07
740.83
35,788.89%
Raw Material Cost
392.30
1.35
390.95
28,959.26%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
59.30
5.17
54.13
1,047.00%
Selling and Distribution Expenses
186.60
31.20
155.40
498.08%
Other Expenses
-0.55
6.36
-6.91
-108.65%
Total Expenditure (Excl Depreciation)
632.70
101.30
531.40
524.58%
Operating Profit (PBDIT) excl Other Income
110.20
-99.23
209.43
211.06%
Other Income
54.20
10.29
43.91
426.72%
Operating Profit (PBDIT)
262.70
-87.60
350.30
399.89%
Interest
59.30
5.17
54.13
1,047.00%
Exceptional Items
-22.30
0.00
-22.30
Gross Profit (PBDT)
350.60
0.72
349.88
48,594.44%
Depreciation
98.30
1.35
96.95
7,181.48%
Profit Before Tax
82.80
-94.11
176.91
187.98%
Tax
30.20
0.79
29.41
3,722.78%
Provisions and contingencies
0
0
0.00
Profit After Tax
52.60
-94.90
147.50
155.43%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
52.60
-94.90
147.50
155.43%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
52.60
-94.90
147.50
155.43%
Equity Capital
0
0
0.00
Face Value
0.00
0.00
0.00
Reserves
522.60
222.48
300.12
134.90%
Earnings per share (EPS)
0.93
-1.45
2.38
164.14%
Diluted Earnings per share
0.93
-1.45
2.38
164.14%
Operating Profit Margin (Excl OI)
14.83%
-4,798.45%
0.00
4,813.28%
Gross Profit Margin
24.38%
-4,485.74%
0.00
4,510.12%
PAT Margin
7.08%
-4,588.83%
0.00
4,595.91%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 74.29 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is -28.81% vs -0.54% in Dec 2024
Annual - Consolidate Net Profit
Consolidate Net Profit 5.26 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is 127.60% vs 74.94% in Dec 2024
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 20.85 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is 288.99% vs 224.94% in Dec 2024
Annual - Interest
Interest 5.93 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is -16.48% vs -26.65% in Dec 2024
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 14.83%
in Dec 2025Figures in %
YoY Growth in year ended Dec 2025 has improved from Dec 2024






